The Multifaceted Role of Cofilin in Neurodegeneration and Stroke: Insights into Pathogenesis and Targeting as a Therapy
Open Access
Abstract
This comprehensive review explores the complex role of cofilin, an actin-binding protein, across various neurodegenerative diseases (Alzheimer’s, Parkinson’s, schizophrenia, amyotrophic lateral sclerosis (ALS), Huntington’s) and stroke. Cofilin is an essential protein in cytoskeletal dynamics, and any dysregulation could lead to potentially serious complications. Cofilin’s involvement is underscored by its impact on pathological hallmarks like Aβ plaques and α-synuclein aggregates, triggering synaptic dysfunction, dendritic spine loss, and impaired neuronal plasticity, leading to cognitive decline. In Parkinson’s disease, cofilin collaborates with α-synuclein, exacerbating neurotoxicity and impairing mitochondrial and axonal function. ALS and frontotemporal dementia showcase cofilin’s association with genetic factors like C9ORF72, affecting actin dynamics and contributing to neurotoxicity. Huntington’s disease brings cofilin into focus by impairing microglial migration and influencing synaptic plasticity through AMPA receptor regulation. Alzheimer’s, Parkinson’s, and schizophrenia exhibit 14-3-3 proteins in cofilin dysregulation as a shared pathological mechanism. In the case of stroke, cofilin takes center stage, mediating neurotoxicity and neuronal cell death. Notably, there is a potential overlap in the pathologies and involvement of cofilin in various diseases. In this context, referencing cofilin dysfunction could provide valuable insights into the common pathologies associated with the aforementioned conditions. Moreover, this review explores promising therapeutic interventions, including cofilin inhibitors and gene therapy, demonstrating efficacy in preclinical models. Challenges in inhibitor development, brain delivery, tissue/cell specificity, and long-term safety are acknowledged, emphasizing the need for precision drug therapy. The call to action involves collaborative research, biomarker identification, and advancing translational efforts. Cofilin emerges as a pivotal player, offering potential as a therapeutic target. However, unraveling its complexities requires concerted multidisciplinary efforts for nuanced and effective interventions across the intricate landscape of neurodegenerative diseases and stroke, presenting a hopeful avenue for improved patient care.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (R01NS112642)
This publication has 153 references indexed in Scilit:
- Cofilin Aggregation Blocks Intracellular Trafficking and Induces Synaptic Loss in Hippocampal NeuronsJournal of Biological Chemistry, 2012
- Rational Approaches to Improving Selectivity in Drug DesignJournal of Medicinal Chemistry, 2012
- A Novel Unbiased Proteomic Approach to Detect the Reactivity of Cerebrospinal Fluid in Neurological DiseasesMolecular & Cellular Proteomics, 2011
- ADF/cofilin-mediated actin dynamics regulate AMPA receptor trafficking during synaptic plasticityNature Neuroscience, 2010
- Learning, AMPA receptor mobility and synaptic plasticity depend on n‐cofilin‐mediated actin dynamicsThe EMBO Journal, 2010
- ADF/Cofilin: a functional node in cell biologyTrends in Cell Biology, 2010
- Structural model and functional significance of pH-dependent talin–actin binding for focal adhesion remodelingProceedings of the National Academy of Sciences, 2008
- Cofilin recruitment and function during actin-mediated endocytosis dictated by actin nucleotide stateJournal of Cell Biology, 2007
- Cofilin promotes stimulus-induced lamellipodium formation by generating an abundant supply of actin monomersJournal of Cell Biology, 2007
- Severing of F-actin by yeast cofilin is pH-independentCell Motility, 2006